Edward Spangenthal, MD
Areas of Expertise:
Clinical and non-invasive cardiology
Cardiology care of the cancer patient
Transesophageal echo and stress echo
Education and Training:
MD - State University of New York, Upstate Medical University, Syracuse, NY
Strong Memorial Hospital, University of Rochester, Rochester, NY
Internal Medicine, American Board of Internal Medicine
Cardiovascular Disease, American Board of Internal Medicine
School of Medicine and Biomedical Sciences, State University of New York at Buffalo
- Reversible cardiotoxicity with tyrosine kinase inhibitors. Clinical advances in hematology and oncology : H&O 2010; 8(2):128-132 .
- Clinical relapse in a patient with multiple myeloma presenting as an atrial plasmacytoma. Journal of clinical oncology 2011; 29(3):e47-e49 .
- Heart failure caused by molecularly targeted therapies for cancer. Pharmacotherapy 2011; 31(1):62-75 .
- Hypertension secondary to anti-angiogenic therapy: experience with bevacizumab. Anticancer research 2007; 27(5B):3465-3470 .